Nine-month, all-oral regimens for rifampin-resistant tuberculosis
Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez, Maelenn Gouillou, Amanzhan Abubakirov, Elisabeth Baudin, Elmira Berikova, Catherine Berry, Maryline Bonnet, Matteo Cellamare, Vijay Chavan, Vivian Cox, Zhanna Dakenova, Bouke Catherine de Jong, Gabriella Ferlazzo, Aydarkhan Karabayev, Ohanna Kirakosyan, Nana Kiria, Mikanda Kunda, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Ilaria Motta, Sergio Mucching-Toscano, Hebah Mushtaque, Payam Nahid, Lawrence Oyewusi, Samiran Panda, Sandip Patil, Patrick Phillips, Jimena Ruiz, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J. Seung, Eduardo Ticona, Lorenzo Trippa, Dante Vargas, Sean Wasserman, Michael L. Rich, Francis Varaine, Carole D. Mitnick
doi: https://doi.org/10.1101/2024.01.29.24301679
Lorenzo Guglielmetti
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Uzma Khan
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Gustavo E. Velásquez
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Maelenn Gouillou
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Amanzhan Abubakirov
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Elisabeth Baudin
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Elmira Berikova
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Catherine Berry
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Maryline Bonnet
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Matteo Cellamare
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Vijay Chavan
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Vivian Cox
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Zhanna Dakenova
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Bouke Catherine de Jong
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Gabriella Ferlazzo
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Aydarkhan Karabayev
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Ohanna Kirakosyan
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Nana Kiria
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Mikanda Kunda
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Nathalie Lachenal
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Leonid Lecca
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Helen McIlleron
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Ilaria Motta
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Sergio Mucching-Toscano
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Hebah Mushtaque
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Payam Nahid
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Lawrence Oyewusi
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Samiran Panda
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Sandip Patil
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Patrick Phillips
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Jimena Ruiz
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Naseem Salahuddin
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Epifanio Sanchez-Garavito
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Kwonjune J. Seung
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Eduardo Ticona
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Lorenzo Trippa
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Dante Vargas
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Sean Wasserman
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Michael L. Rich
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Francis Varaine
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Carole D. Mitnick
1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
Article Information
History
- January 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lorenzo Guglielmetti1,*,
- Uzma Khan1,*,
- Gustavo E. Velásquez1,*,
- Maelenn Gouillou1,
- Amanzhan Abubakirov1,
- Elisabeth Baudin1,
- Elmira Berikova1,
- Catherine Berry1,
- Maryline Bonnet1,
- Matteo Cellamare1,
- Vijay Chavan1,
- Vivian Cox1,
- Zhanna Dakenova1,
- Bouke Catherine de Jong1,
- Gabriella Ferlazzo1,
- Aydarkhan Karabayev1,
- Ohanna Kirakosyan1,
- Nana Kiria1,
- Mikanda Kunda1,
- Nathalie Lachenal1,
- Leonid Lecca1,
- Helen McIlleron1,
- Ilaria Motta1,
- Sergio Mucching-Toscano1,
- Hebah Mushtaque1,
- Payam Nahid1,
- Lawrence Oyewusi1,
- Samiran Panda1,
- Sandip Patil1,
- Patrick Phillips1,
- Jimena Ruiz1,
- Naseem Salahuddin1,
- Epifanio Sanchez-Garavito1,
- Kwonjune J. Seung1,
- Eduardo Ticona1,
- Lorenzo Trippa1,
- Dante Vargas1,
- Sean Wasserman1,
- Michael L. Rich1,
- Francis Varaine1,** and
- Carole D. Mitnick1,**,#
- 1Médecins Sans Frontières, Paris (L.G., F.V.); Sorbonne Université, National Institute of Health and Medical Research (INSERM), U1135, Centre d’Immunologie Et Des Maladies Infectieuses, Paris (L.G.); Assistance Publique Hôpitaux de Paris (APHP), Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié Salpêtrière, Centre National De Référence Des Mycobactéries Et De La Résistance Des Mycobactéries Aux Antituberculeux, Paris (L.G.); Interactive Development and Research, Singapore, Singapore (U.K.); McGill University, Epidemiology, Biostatistics and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis, University of California San Francisco, San Francisco (G.E.V., P.N., P.P); Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco (G.E.V.); National Scientific Center of Phthisiopulmonology, Almaty (A.A., E.B.); Epicentre, Paris (M.G., E.B.); Médecins Sans Frontières, London (C.B., I.M.); Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier (M.B.); Université de Montpellier, Montpellier (M.B.); Institut de recherche pour le développement, Marseille (M.B.); National Institute of Health and Medical Research (INSERM), Paris (M.B.); Medstar Health Research Institute, Washington D.C. (M.C.); Médecins Sans Frontières, Mumbai (V.C.); Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town (V.C.); City Center of Phthisiopulmonology, Astana (Z.D.); Institute of Tropical Medicine, Antwerp (B. C. dJ); Médecins Sans Frontières, Geneva (G.F., M.L.); Center of Phthisiopulmonology of Almaty Health Department, Almaty (A.K.); Médecins Sans Frontières, Yerevan (O.K.); National Center for Tuberculosis and Lung Diseases, Tbilisi (N.K.); Partners In Health, Maseru (M.K); Socios En Salud Sucursal Peru, Lima (L.L., S.M-T., J.R., E. S-G.,D.E.V-V.); Global Health and Social Medicine, Harvard Medical School (L.L., C.D.M.); Department of Medicine, University of Cape Town, Cape Town (H.M.); Medical Research Council Clinical Trials Unit at University College London, London (I.M); The Indus Hospital and Health Network, Karachi (H.M., N.S.); Jhpiego Lesotho, Maseru (L.O.); Indian Council of Medical Research Headquarters - New Delhi, New Delhi (S.P.); Indian Council of Medical Research-National AIDS Research Institute, Pune (S.P.); Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas, Lima (E.S-G.); Partners In Health, Boston (K.J.S, M.L.R); Division of Global Health Equity, Brigham and Women’s Hospital, Boston (K.J.S, M.L.R., C.D.M.); Hospital Nacional Dos de Mayo, Lima (E.R.T); Universidad Nacional Mayor de San Marcos, Lima (E.R.T.); Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston (L.T.); Harvard University T.H. Chan School of Public Health, Boston (L.T); Hospital Nacional Hipólito Unanue, Lima (D.E.V-V); St George’s University of London Institute for Infection and Immunity, London (S.W.); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Cape Town (S.W.)
- ↵#Corresponding Author:
Carole D. Mitnick (carole_mitnick{at}hms.harvard.edu)
Posted January 29, 2024.
Nine-month, all-oral regimens for rifampin-resistant tuberculosis
Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez, Maelenn Gouillou, Amanzhan Abubakirov, Elisabeth Baudin, Elmira Berikova, Catherine Berry, Maryline Bonnet, Matteo Cellamare, Vijay Chavan, Vivian Cox, Zhanna Dakenova, Bouke Catherine de Jong, Gabriella Ferlazzo, Aydarkhan Karabayev, Ohanna Kirakosyan, Nana Kiria, Mikanda Kunda, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Ilaria Motta, Sergio Mucching-Toscano, Hebah Mushtaque, Payam Nahid, Lawrence Oyewusi, Samiran Panda, Sandip Patil, Patrick Phillips, Jimena Ruiz, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J. Seung, Eduardo Ticona, Lorenzo Trippa, Dante Vargas, Sean Wasserman, Michael L. Rich, Francis Varaine, Carole D. Mitnick
medRxiv 2024.01.29.24301679; doi: https://doi.org/10.1101/2024.01.29.24301679
Nine-month, all-oral regimens for rifampin-resistant tuberculosis
Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez, Maelenn Gouillou, Amanzhan Abubakirov, Elisabeth Baudin, Elmira Berikova, Catherine Berry, Maryline Bonnet, Matteo Cellamare, Vijay Chavan, Vivian Cox, Zhanna Dakenova, Bouke Catherine de Jong, Gabriella Ferlazzo, Aydarkhan Karabayev, Ohanna Kirakosyan, Nana Kiria, Mikanda Kunda, Nathalie Lachenal, Leonid Lecca, Helen McIlleron, Ilaria Motta, Sergio Mucching-Toscano, Hebah Mushtaque, Payam Nahid, Lawrence Oyewusi, Samiran Panda, Sandip Patil, Patrick Phillips, Jimena Ruiz, Naseem Salahuddin, Epifanio Sanchez-Garavito, Kwonjune J. Seung, Eduardo Ticona, Lorenzo Trippa, Dante Vargas, Sean Wasserman, Michael L. Rich, Francis Varaine, Carole D. Mitnick
medRxiv 2024.01.29.24301679; doi: https://doi.org/10.1101/2024.01.29.24301679
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)